Tag | Content |
---|
EnhancerAtlas ID | HS023-11414 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr17:78704510-78706530 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Arid3b | MA0601.1 | chr17:78705342-78705353 | TTAATTAATAT | - | 6.62 | Foxd3 | MA0041.1 | chr17:78705779-78705791 | GTTTGTTTGTTT | + | 6.32 | LMX1B | MA0703.2 | chr17:78705339-78705350 | GTTTTAATTAA | + | 6.14 | LMX1B | MA0703.2 | chr17:78706089-78706100 | TTAATTAAAAC | - | 6.14 | RREB1 | MA0073.1 | chr17:78704559-78704579 | GGGGTGGGGTTTGGGTGGGG | - | 6.27 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_18686 | chr17:78704412-78706057 | CD4p_CD25-_Il17-_PMAstim_Th | SE_30912 | chr17:78704060-78705899 | Fetal_Thymus | SE_58375 | chr17:78693364-78765651 | Ly1 | SE_59618 | chr17:78705193-78766611 | Ly4 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I080730 | chr17 | 78704649 | 78705652 | GH17I080731 | chr17 | 78705694 | 78706685 |
|
Enhancer Sequence | GCGCTCTGGT GCTTGGAGAG CGGTGCTGGG TTTGGTTTTG TTTTCCCTGG GGGTGGGGTT 60 TGGGTGGGGA GGTTGGGAGG TGTTGGACAT CCTCTGAATG GAGCAGGGCT CAGAATGCCA 120 AGGGCAGGAT GGCATATTCA ATGCTGTTGA GCTAGGGAGG CACTCAGCAC ACTTTATTTT 180 TGAAACATAA TCTTGTTCTG TTGCCCAGGC TGGAGTGCTG TGGTGCCGTC TCCAGTCACT 240 GCAATGTCTG TCACCTGAGC CCAAGCAATC TTCCCTTCTC AGCCTCCTGA GTAGCTGAGA 300 CTACAGGTGC ACGCCACGCC ACCATGCCTA GCTAATTTTT GTAGTTTTTG TAGAGGTGGT 360 GTTTCGCCAT GTTTCTCAGC CTGGTCTCAA ACTCCTGGGC TCAAGCAACG CGTGTGCCTC 420 AGCCTGCAAA GTTCTGGGAT TACAGGCTTG AGCACTGAGC CCGGCCCAGT ACAAACCTAC 480 AGACTTATTT TTACATCTCA TTTTACTCAG TGTCATTTTT AATCCAAACA TTAATTGATA 540 ACATTCATAG GGTCGATTTG TGCCCCAGCA GTCTCTGCCT CCAAGATAAA TGTGAAAATA 600 AAGCAGACAC ATTTATTTTA GGAGAAATGG ACCCACAGCT TCAGTTCCAC CAGTGCCTTT 660 GTTCCTGCCC CGGTTTCTTT TTCTGTTGTG TTAAAAAAAA AAAAATCCCC GAAAACCACT 720 AAGCTAAAAT GATAGAAAAC AAACGAAAAC AGCTACTGTT GTAGCGCCCA CTTCAAAAAG 780 CGGAAAGCCT GTGCACCGCT CTGCTAATGA AGAGACATTT TGCTTGGTTG TTTTAATTAA 840 TATTTGATGT TTGAATTAAA CAGTGAATTC TGAGGACAAA TTGAAGAGGC AGTTTCGATT 900 AAGAGGCCTC CATCTTGTGG CCTGCACAAG AGTGTCAGAA TGAAATATTC TGCAGCCTCA 960 AGGGGGTCAT GAGTTCTACT GGTTGCAGTA TAGGAAATTC TCAATTTAGG AGCAAAAATG 1020 ATCTTGAGTA TGTTTCCTCA AGCCTTTTTG AATATATTCA ATTTTAATGT ATTATGTTTT 1080 CACATTTCAT CATAGAAAAA TGCTGAAACA ATCAGTAACA AAATTTGAAA TTCTGTTTGG 1140 TAGATTTTCA CATTAACATG TGTACAGTTG AATATTTTAT AATTATTAAT TCTTTATGTG 1200 GAACACCGCA AAAGAGTGAC TGATAAGTAT AATGTGGTTT ATCCATGAAA AAGGATCCAC 1260 ATGCAACAAG TTTGTTTGTT TTGTTTTCTA TGATAAGGGA AAGAAAGATC AAGGTTTGTA 1320 TCATCAGATT TTTCCCTTGC TTTCAGGCAT TTCATCTTGG TTTACCCAGG GGATAGGTTA 1380 TCTAATGAGC ATTAAGAAAC TCAAAGCATT GAGAGGTAAT TTATTTTTCC TTGCATCAAG 1440 TAATAAATAT CGCAAAAAAA AGGTGATTTT TTTACATTTA TAATATGTAA ATAAAAATGC 1500 CAAAGAATCC TGCCTGAGTT CTACACCAGA TTTATGGGCT GGAGAGTGGT TAAGGGAAAG 1560 ACCAATACAT CAGCCTCAGT TAATTAAAAC ATGTTAAATA GAGACCCGCT CCCCTTTCAG 1620 CAGAAGACCA GCACCTCCAG CTCATGCATA ATACCAAATG CTTGCATTCC AGCGCTTTGA 1680 GCATGTGCTC CGGCAGTGCT GTGTGTGCTC TCTGTGTGTT GCCAGGGATT AATCAGCCTA 1740 AGACACTGTT CATTTCATCA AGTGTAACAG AAAAGATTCC CATGCATCTT TTTTAGGAAA 1800 AAAAAATGTT TGACTCATTC CACATGAAAG AGATCAGATG AAAAATATGT TAACTGAGTT 1860 GGCGAATAGA TGGCAAGGCA ATGCGATACC GTATGTCTTT AATTAGCTCT GATTTTTATC 1920 TTCGTTCTTT AATTACAATG TAGATCAGTC TTGTGTGTTT CTATTACACT TACTATTATT 1980 GGCTATTGTT CACTTGGTCT CTTATAAAAA CAGTGGAAAT 2020
|